A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide

β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affected by relapsing-remitting MS, who attempted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmacology & pharmacotherapeutics 2013-12, Vol.4 (Suppl 1), p.S90-S93
Hauptverfasser: Mumoli, Laura, Ciriaco, Miriam, Gambardella, Antonio, Bombardiere, Giuseppe Nicodemo, Valentino, Paola, Palleria, Caterina, Labate, Angelo, Russo, Emilio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S93
container_issue Suppl 1
container_start_page S90
container_title Journal of pharmacology & pharmacotherapeutics
container_volume 4
creator Mumoli, Laura
Ciriaco, Miriam
Gambardella, Antonio
Bombardiere, Giuseppe Nicodemo
Valentino, Paola
Palleria, Caterina
Labate, Angelo
Russo, Emilio
description β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affected by relapsing-remitting MS, who attempted suicide during natalizumab treatment. This case suggests that a suicidal ideation might be a rare side effect of natalizumab. Nevertheless, this case represents the first evidence of the new adverse drug reaction related to natalizumab treatment. We should alert clinicians to be aware of the possibility of paradoxical activation of suicidality during its therapeutic use. The main purpose of the present article is to use this case to review the possible relationship between suicidal behavior and drugs.
doi_str_mv 10.4103/0976-500X.120974
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3853678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A351379977</galeid><sourcerecordid>A351379977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-6164f79eb68b98d83ccd57296f6c2aa2f9178162ff5d741676f860da99ced2fa3</originalsourceid><addsrcrecordid>eNptUk1r3DAQNaWlCWnuPRVBoTdvJUuWrB4KS0g_INBLC7mpsjTaVbAtV5JTml9fLbvZZqHSQcPovcfMvKmq1wSvGMH0PZaC1y3GtyvSlJg9q84PKdI9P8b49qy6TOkOl0Mlw0y-rM4aRpmQkpxXP9doDin5fgBkdAIUHJp01oN_WEbd1xZmmCxMGaXFG28B6ZxhnPMHtEZ99OBQhHsPv5Huw5KRjcsmIT3ZR_yr6oXTQ4LLw3tR_fh0_f3qS33z7fPXq_VNbVgnc80JZ05I6HnXy8521BjbikZyx02jdeMkER3hjXOtFYxwwV3HsdVSGrCN0_Si-rjXnZd-BGtKyVEPao5-1PGPCtqr05_Jb9Um3CvatZSLrgi8PQjE8GuBlNVdWOJUalaEcSYoIYL-Q230AMpPLhQxM_pk1Jq2hJapClFQq_-gyrUwehMmcL7kTwjvnhC2oIe8TWFYsg9TOgXiPdDEYlsEd-yQYLVbC7XzXe18V_u1KJQ3TydzJDwuAf0Lhc-xkw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1464731173</pqid></control><display><type>article</type><title>A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide</title><source>Sage Journals GOLD Open Access 2024</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Mumoli, Laura ; Ciriaco, Miriam ; Gambardella, Antonio ; Bombardiere, Giuseppe Nicodemo ; Valentino, Paola ; Palleria, Caterina ; Labate, Angelo ; Russo, Emilio</creator><creatorcontrib>Mumoli, Laura ; Ciriaco, Miriam ; Gambardella, Antonio ; Bombardiere, Giuseppe Nicodemo ; Valentino, Paola ; Palleria, Caterina ; Labate, Angelo ; Russo, Emilio</creatorcontrib><description>β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affected by relapsing-remitting MS, who attempted suicide during natalizumab treatment. This case suggests that a suicidal ideation might be a rare side effect of natalizumab. Nevertheless, this case represents the first evidence of the new adverse drug reaction related to natalizumab treatment. We should alert clinicians to be aware of the possibility of paradoxical activation of suicidality during its therapeutic use. The main purpose of the present article is to use this case to review the possible relationship between suicidal behavior and drugs.</description><identifier>ISSN: 0976-500X</identifier><identifier>EISSN: 0976-5018</identifier><identifier>DOI: 10.4103/0976-500X.120974</identifier><identifier>PMID: 24347991</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Addictive behaviors ; Care and treatment ; Case Review ; Case studies ; Emotional disorders ; Inventory ; Multiple sclerosis ; NMR ; Nuclear magnetic resonance ; Patients ; Risk factors ; Self destructive behavior ; Studies ; Substance abuse treatment ; Suicidal behavior ; Suicides &amp; suicide attempts</subject><ispartof>Journal of pharmacology &amp; pharmacotherapeutics, 2013-12, Vol.4 (Suppl 1), p.S90-S93</ispartof><rights>COPYRIGHT 2013 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Dec 2013</rights><rights>Copyright: © Journal of Pharmacology and Pharmacotherapeutics 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-6164f79eb68b98d83ccd57296f6c2aa2f9178162ff5d741676f860da99ced2fa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853678/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853678/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24347991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mumoli, Laura</creatorcontrib><creatorcontrib>Ciriaco, Miriam</creatorcontrib><creatorcontrib>Gambardella, Antonio</creatorcontrib><creatorcontrib>Bombardiere, Giuseppe Nicodemo</creatorcontrib><creatorcontrib>Valentino, Paola</creatorcontrib><creatorcontrib>Palleria, Caterina</creatorcontrib><creatorcontrib>Labate, Angelo</creatorcontrib><creatorcontrib>Russo, Emilio</creatorcontrib><title>A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide</title><title>Journal of pharmacology &amp; pharmacotherapeutics</title><addtitle>J Pharmacol Pharmacother</addtitle><description>β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affected by relapsing-remitting MS, who attempted suicide during natalizumab treatment. This case suggests that a suicidal ideation might be a rare side effect of natalizumab. Nevertheless, this case represents the first evidence of the new adverse drug reaction related to natalizumab treatment. We should alert clinicians to be aware of the possibility of paradoxical activation of suicidality during its therapeutic use. The main purpose of the present article is to use this case to review the possible relationship between suicidal behavior and drugs.</description><subject>Addictive behaviors</subject><subject>Care and treatment</subject><subject>Case Review</subject><subject>Case studies</subject><subject>Emotional disorders</subject><subject>Inventory</subject><subject>Multiple sclerosis</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Patients</subject><subject>Risk factors</subject><subject>Self destructive behavior</subject><subject>Studies</subject><subject>Substance abuse treatment</subject><subject>Suicidal behavior</subject><subject>Suicides &amp; suicide attempts</subject><issn>0976-500X</issn><issn>0976-5018</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUk1r3DAQNaWlCWnuPRVBoTdvJUuWrB4KS0g_INBLC7mpsjTaVbAtV5JTml9fLbvZZqHSQcPovcfMvKmq1wSvGMH0PZaC1y3GtyvSlJg9q84PKdI9P8b49qy6TOkOl0Mlw0y-rM4aRpmQkpxXP9doDin5fgBkdAIUHJp01oN_WEbd1xZmmCxMGaXFG28B6ZxhnPMHtEZ99OBQhHsPv5Huw5KRjcsmIT3ZR_yr6oXTQ4LLw3tR_fh0_f3qS33z7fPXq_VNbVgnc80JZ05I6HnXy8521BjbikZyx02jdeMkER3hjXOtFYxwwV3HsdVSGrCN0_Si-rjXnZd-BGtKyVEPao5-1PGPCtqr05_Jb9Um3CvatZSLrgi8PQjE8GuBlNVdWOJUalaEcSYoIYL-Q230AMpPLhQxM_pk1Jq2hJapClFQq_-gyrUwehMmcL7kTwjvnhC2oIe8TWFYsg9TOgXiPdDEYlsEd-yQYLVbC7XzXe18V_u1KJQ3TydzJDwuAf0Lhc-xkw</recordid><startdate>201312</startdate><enddate>201312</enddate><creator>Mumoli, Laura</creator><creator>Ciriaco, Miriam</creator><creator>Gambardella, Antonio</creator><creator>Bombardiere, Giuseppe Nicodemo</creator><creator>Valentino, Paola</creator><creator>Palleria, Caterina</creator><creator>Labate, Angelo</creator><creator>Russo, Emilio</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Sage Publications Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>201312</creationdate><title>A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide</title><author>Mumoli, Laura ; Ciriaco, Miriam ; Gambardella, Antonio ; Bombardiere, Giuseppe Nicodemo ; Valentino, Paola ; Palleria, Caterina ; Labate, Angelo ; Russo, Emilio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-6164f79eb68b98d83ccd57296f6c2aa2f9178162ff5d741676f860da99ced2fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Addictive behaviors</topic><topic>Care and treatment</topic><topic>Case Review</topic><topic>Case studies</topic><topic>Emotional disorders</topic><topic>Inventory</topic><topic>Multiple sclerosis</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Patients</topic><topic>Risk factors</topic><topic>Self destructive behavior</topic><topic>Studies</topic><topic>Substance abuse treatment</topic><topic>Suicidal behavior</topic><topic>Suicides &amp; suicide attempts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mumoli, Laura</creatorcontrib><creatorcontrib>Ciriaco, Miriam</creatorcontrib><creatorcontrib>Gambardella, Antonio</creatorcontrib><creatorcontrib>Bombardiere, Giuseppe Nicodemo</creatorcontrib><creatorcontrib>Valentino, Paola</creatorcontrib><creatorcontrib>Palleria, Caterina</creatorcontrib><creatorcontrib>Labate, Angelo</creatorcontrib><creatorcontrib>Russo, Emilio</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of pharmacology &amp; pharmacotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mumoli, Laura</au><au>Ciriaco, Miriam</au><au>Gambardella, Antonio</au><au>Bombardiere, Giuseppe Nicodemo</au><au>Valentino, Paola</au><au>Palleria, Caterina</au><au>Labate, Angelo</au><au>Russo, Emilio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide</atitle><jtitle>Journal of pharmacology &amp; pharmacotherapeutics</jtitle><addtitle>J Pharmacol Pharmacother</addtitle><date>2013-12</date><risdate>2013</risdate><volume>4</volume><issue>Suppl 1</issue><spage>S90</spage><epage>S93</epage><pages>S90-S93</pages><issn>0976-500X</issn><eissn>0976-5018</eissn><abstract>β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affected by relapsing-remitting MS, who attempted suicide during natalizumab treatment. This case suggests that a suicidal ideation might be a rare side effect of natalizumab. Nevertheless, this case represents the first evidence of the new adverse drug reaction related to natalizumab treatment. We should alert clinicians to be aware of the possibility of paradoxical activation of suicidality during its therapeutic use. The main purpose of the present article is to use this case to review the possible relationship between suicidal behavior and drugs.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>24347991</pmid><doi>10.4103/0976-500X.120974</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0976-500X
ispartof Journal of pharmacology & pharmacotherapeutics, 2013-12, Vol.4 (Suppl 1), p.S90-S93
issn 0976-500X
0976-5018
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3853678
source Sage Journals GOLD Open Access 2024; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Addictive behaviors
Care and treatment
Case Review
Case studies
Emotional disorders
Inventory
Multiple sclerosis
NMR
Nuclear magnetic resonance
Patients
Risk factors
Self destructive behavior
Studies
Substance abuse treatment
Suicidal behavior
Suicides & suicide attempts
title A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A20%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20possible%20case%20of%20natalizumab-dependent%20suicide%20attempt:%20A%20brief%20review%20about%20drugs%20and%20suicide&rft.jtitle=Journal%20of%20pharmacology%20&%20pharmacotherapeutics&rft.au=Mumoli,%20Laura&rft.date=2013-12&rft.volume=4&rft.issue=Suppl%201&rft.spage=S90&rft.epage=S93&rft.pages=S90-S93&rft.issn=0976-500X&rft.eissn=0976-5018&rft_id=info:doi/10.4103/0976-500X.120974&rft_dat=%3Cgale_pubme%3EA351379977%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1464731173&rft_id=info:pmid/24347991&rft_galeid=A351379977&rfr_iscdi=true